The medication has a long half-life that provides consistent blood levels throughout the week regardless of injection time
Lowering peripheral insulin level via using other antidiabetic drugs is feasible, but therapies targeting insulin signal pathways still needs a long way to go at present
[DOI] [PMC free article] [PubMed] [Google Scholar] 50.Heise T, Mari A, DeVries JH, Urva S, Li J, Pratt EJ, Coskun T, Thomas MK, Mather KJ, Haupt A, et al
Benefits Supports metabolic health
GLP-1 patches and novel delivery systems aim to make administration even easier
Background Inflammatory bowel disease (IBD) is an idiopathic condition characterized by chronic relapsing inflammation in the gastrointestinal tract